Lowering inflammation reduces cardio risk

Researchers from Harvard University found that reducing systemic inflammation significantly reduced the risk of a second heart attack, independent of changes in cholesterol. Cholesterol lowering drugs also reduce inflammation, raising questions about whether their cardio protective benefits were due to lower cholesterol or lower inflammation. This study helps to separate the two issues and confirms inflammation as an independent risk factor for heart disease.

Read more about this research.